IKS - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.2
| Stock Code | IKS | Market Cap | 27,123 Cr. | Current Price | 1,580 ₹ | High / Low | 1,876 ₹ |
| Stock P/E | 47.9 | Book Value | 104 ₹ | Dividend Yield | 0.00 % | ROCE | 44.0 % |
| ROE | 37.6 % | Face Value | 1.00 ₹ | DMA 50 | 1,552 ₹ | DMA 200 | 1,574 ₹ |
| Chg in FII Hold | 0.63 % | Chg in DII Hold | 0.34 % | PAT Qtr | 169 Cr. | PAT Prev Qtr | 146 Cr. |
| RSI | 54.2 | MACD | 40.0 | Volume | 76,981 | Avg Vol 1Wk | 1,26,611 |
| Low price | 1,262 ₹ | High price | 1,876 ₹ | PEG Ratio | 1.80 | Debt to equity | 0.06 |
| 52w Index | 51.8 % | Qtr Profit Var | 69.3 % | EPS | 33.0 ₹ | Industry PE | 26.2 |
📊 Core Financials: IKS demonstrates strong fundamentals with ROCE at 44.0% and ROE at 37.6%, reflecting excellent capital efficiency. Debt-to-equity ratio of 0.06 highlights a low-leverage structure. Quarterly PAT of ₹169 Cr. improved from ₹146 Cr., showing consistent growth. EPS of ₹33.0 supports earnings strength and profitability momentum.
💰 Valuation Indicators: Current P/E of 47.9 is significantly above the industry average of 26.2, suggesting overvaluation. P/B ratio of ~15.2 (1580/104) reflects premium pricing. PEG ratio of 1.80 indicates growth is fairly priced but not cheap. Dividend yield of 0% offers no income return. Intrinsic value appears lower than current price, requiring cautious entry.
🏢 Business Model & Competitive Advantage: IKS operates with a strong business model, leveraging innovation and efficiency. Its competitive advantage lies in high profitability, strong institutional support, and low debt. Consistent profit growth and scalability strengthen its long-term outlook.
📈 Entry Zone: RSI at 54.2 suggests neutral momentum, while MACD positive indicates bullish trend. Current price of ₹1,580 is near DMA levels (50 DMA: ₹1,552, 200 DMA: ₹1,574). Entry between ₹1,500–₹1,550 may be favorable for long-term investors.
⏳ Long-Term Holding Guidance: Strong fundamentals, low debt, and consistent profitability make IKS a solid candidate for long-term holding. However, high valuation warrants cautious entry. Investors should accumulate near support levels for compounding potential.
Positive
- 🌟 High ROCE (44.0%) and ROE (37.6%)
- 🌟 Low debt-to-equity ratio (0.06)
- 🌟 Consistent quarterly PAT growth (₹146 Cr. → ₹169 Cr.)
- 🌟 Strong institutional interest (FII +0.63%, DII +0.34%)
Limitation
- ⚠️ High P/E (47.9) compared to industry average (26.2)
- ⚠️ P/B ratio of 15.2 indicates premium valuation
- ⚠️ No dividend yield
Company Negative News
- 📉 Valuation concerns due to high P/E and P/B
Company Positive News
- 📈 Strong quarterly profit growth (+69.3%)
- 📈 Increase in both FII and DII holdings
Industry
- 🌐 Industry P/E at 26.2 reflects moderate valuation
- 🌐 Sector growth supported by demand and innovation
- 🌐 IKS positioned well with strong profitability and efficiency
Conclusion
✅ IKS shows strong fundamentals, efficient capital returns, and low debt. Entry between ₹1,500–₹1,550 is favorable for long-term investors. While valuations are high, consistent profitability and institutional support make it a reliable candidate for compounding wealth.
Would you like me to also compare IKS with peers such as Persistent Systems or LTIMindtree to highlight sector positioning?